Stereotactic radiation therapy of brain metastases is a treatment recognized as effective, well tolerated, applicable for therapeutic indications codified and validated by national and international guidelines. However, the effectiveness of this irradiation, the evolution of patient care and the technical improvements enabling its implementation make it possible to consider it in more complex situations: proximity of brain metastases to organs at risk; large, cystic, haemorrhagic or multiple brain metastases, combination with targeted therapies and immunotherapy, stereotactic radiotherapy in patients with a pacemaker. This article aims to put forward the arguments available to date in the literature and those resulting from clinical practice to provide decision support for the radiation oncologists.
Keywords: Brain metastasis; Cyst; Haemorrhage; Hémorragie; Immunotherapy; Immunothérapie; Kyste; Multiple metastasis; Métastases cérébrales; Métastases multiples; Organes à risque; Organs at risk; Pace-maker; Size; Stereotactic irradiation; Stéréotaxie; Taille; Targeted therapy; Thérapie ciblée.
Copyright © 2019. Published by Elsevier Masson SAS.